Governors Lane’s Envoy Medical COCH Stock Holding History

Governors Lane’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$2M	–	75
2022 Q4	$2M	Hold	200,000	–	–	0.21%	106
2022 Q3	$1.96M	Hold	200,000	–	–	0.17%	149
2022 Q2	$1.96M	Hold	200,000	–	–	0.16%	157
2022 Q1	$1.95M	Hold	200,000	–	–	0.14%	148
2021 Q4	$1.95M	Hold	200,000	–	–	0.12%	174
2021 Q3	$1.94M	Buy	+200,000	New	+$1.94M	0.13%	137

Other funds holding COCH

AMC

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Governors Lane's COCH Position: Q1 2023 in Review

Governors Lane sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 200,000 shares — an estimated $2M sold.

Governors Lane first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $2M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Governors Lane reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Governors Lane sold 200,000 Envoy Medical shares in Q1 2023, an estimated $2M.
Governors Lane first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
Governors Lane's Envoy Medical position peaked at $2M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Governors Lane's 13F filing for Q1 2023, filed 15 May 2023.